SDHA and Miyoshi myopathy: In vitro, we verified SDHA overexpression led MM cells to be low proliferative and invasive and high synergistic effect under chidamide and bortezomib or lenalidomide treatment, which indicated that high expression of SDHA was a good prognostic factor of MM.